Clinical Trial Matching

Selected news for the healthcare topic - Clinical Trial Matching, collected since 1/2018. There are 146 items in the archive. This healthcare topic shares news with Oncology, Anderson, Indiana, Precision Medicine and many others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
3/22/2022 Milltrust Ventures to Invest in First-In-Class Health Tech Platform Oncoshot PR Newswire ... ecosystems, and Asia , particularly Singapore , home to a thriving start-up ecosystem with strong backing and support from good policies and government assistance.Oncoshot is a health insights exchange platform that leverages its proprietary clinical trial matching artificial intelligence (AI) technology to address the inefficiencies of cancer clinical trials. The platform serves as a bridge between leading regional healthcare institutions and contract research organizations (CROs) and global biotechnology and pharmaceutical ...
3/22/2022 Milltrust Ventures to Invest in First-In-Class Health Tech Platform Oncoshot Yahoo News ... ecosystems, and Asia , particularly Singapore , home to a thriving start-up ecosystem with strong backing and support from good policies and government assistance.Oncoshot is a health insights exchange platform that leverages its proprietary clinical trial matching artificial intelligence (AI) technology to address the inefficiencies of cancer clinical trials. The platform serves as a bridge between leading regional healthcare institutions and contract research organizations (CROs) and global biotechnology and pharmaceutical ...
3/10/2022 Pyramid Biosciences and Caris Life Sciences Announce MI Trials Collaboration for Clinical Trial Matching in Support of Study for Patients with NTRK Fusion Solid Tumors PR Newswire WALTHAM, Mass. and IRVING, Texas Pyramid Biosciences, Inc ., and Caris Life Sciences ® (Caris), today announced a collaboration to enhance identification of potential patients with NTRK fusion-driven cancers for participation in the ongoing Phase 1/2 trial (PBI-200-101) of Pyramid's lead oncology program PBI-200, a best-in-class, next-generation, highly CNS-penetrant TRK inhibitor . Pyramid Biosciences is a clinical-stage biotechnology company developing a portfolio of precision ...
2/11/2022 NHS Cancer Alliance implements Inspirata's AI technology to boost trial access clinicaltrialsarena.com ... appropriate clinical trials.In the initial stage, the software will be deployed at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW).This is the first stage of a multicentre roll-out of the clinical trial matching solution that could help patients throughout the region.Inspirata’s software leverages oncology-specific natural language processing (NLP) AI to eradicate usual constraints in the trial matching workflow.It operates with the trust ...
2/10/2022 NHS Cancer Alliance Implements Inspirata AI to Improve Globe Newswire ... partnership involves an initial implementation of Inspirata’s Trial Navigator™ software at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), as the first step of a multi-site roll-out of the clinical trial matching solution for the benefit of patients across the geography. This initiative is part of the alliance’s long-standing aim of improving clinical trial access.“We are excited to partner with Inspirata in ...
2/10/2022 NHS Cancer Alliance Implements Inspirata AI to Improve Globe Newswire ... partnership involves an initial implementation of Inspirata’s Trial Navigator™ software at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), as the first step of a multi-site roll-out of the clinical trial matching solution for the benefit of patients across the geography. This initiative is part of the alliance’s long-standing aim of improving clinical trial access.“We are excited to partner with Inspirata in ...
2/10/2022 NHS Cancer Alliance Implements Inspirata AI to Improve Clinical Trial Access for South West Patients Globe Newswire ... partnership involves an initial implementation of Inspirata’s Trial Navigator™ software at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), as the first step of a multi-site roll-out of the clinical trial matching solution for the benefit of patients across the geography. This initiative is part of the alliance’s long-standing aim of improving clinical trial access.“We are excited to partner with Inspirata in ...
12/17/2021 Deep Lens and Ventura County Hematology Oncology Specialists Partner to Expand Clinical Trial Offering for Cancer Patients Yahoo News ... strategic agreement that will expand clinical trial opportunities for patients in the Ventura county area. As part of this collaboration, Ventura County Hematology Oncology Specialists will integrate Deep Lens’ artificial intelligence (AI) based clinical trial matching solution and other services to identify patients for trials faster and more effectively. Ventura County Hematology Oncology Specialists is a comprehensive cancer center serving patients across Ventura and the surrounding coastal communities. Deep ...
12/17/2021 Deep Lens and Ventura County Hematology Oncology Specialists Partner to Expand Clinical Trial Offering for Cancer Patients | Business Wire Business Wire ... strategic agreement that will expand clinical trial opportunities for patients in the Ventura county area. As part of this collaboration, Ventura County Hematology Oncology Specialists will integrate Deep Lens’ artificial intelligence (AI) based clinical trial matching solution and other services to identify patients for trials faster and more effectively. Ventura County Hematology Oncology Specialists is a comprehensive cancer center serving patients across Ventura and the surrounding coastal communities. Deep ...
12/17/2021 Deep Lens and Ventura County Hematology Oncology Specialists Partner to Expand Clinical Trial Offering for Cancer Patients | Business & Finance | citizentribune.com citizentribune.com ... strategic agreement that will expand clinical trial opportunities for patients in the Ventura county area. As part of this collaboration, Ventura County Hematology Oncology Specialists will integrate Deep Lens’ artificial intelligence (AI) based clinical trial matching solution and other services to identify patients for trials faster and more effectively. Ventura County Hematology Oncology Specialists is a comprehensive cancer center serving patients across Ventura and the surrounding coastal communities. Deep ...
12/17/2021 Deep Lens and Ventura County Hematology Oncology Specialists Partner to Expand Clinical Trial Offering for Cancer Patients | Business | Maryville Daily Forum maryvilleforum.com ... strategic agreement that will expand clinical trial opportunities for patients in the Ventura county area. As part of this collaboration, Ventura County Hematology Oncology Specialists will integrate Deep Lens’ artificial intelligence (AI) based clinical trial matching solution and other services to identify patients for trials faster and more effectively. Ventura County Hematology Oncology Specialists is a comprehensive cancer center serving patients across Ventura and the surrounding coastal communities. Deep ...
12/17/2021 Deep Lens and Ventura County Hematology Oncology Specialists Partner to Expand Clinical Trial Offering for Cancer Patients | News | bakersfield.com bakersfield.com ... strategic agreement that will expand clinical trial opportunities for patients in the Ventura county area. As part of this collaboration, Ventura County Hematology Oncology Specialists will integrate Deep Lens’ artificial intelligence (AI) based clinical trial matching solution and other services to identify patients for trials faster and more effectively. Ventura County Hematology Oncology Specialists is a comprehensive cancer center serving patients across Ventura and the surrounding coastal communities. Deep ...
12/14/2021 Massive Bio Launches Plan to Enroll 100K Cancer Patients Into Clinical Trials | Genomeweb genomeweb.com CHICAGO – Massive Bio last week introduced an ambitious plan to apply artificial intelligence to improve clinical trial matching for cancer patients.The New York-based bioinformatics company said that it wants to get 100,000 people into clinical trials to accelerate research and improve outcomes for cancer patients worldwide through what it has named the 100K Cancer Clinical Trial Singularity Program."Singularity" is a term in the technology world describing ...
12/9/2021 Outcomes4Me Announces Results from a Breast Cancer Patient Study Conducted in Collaboration with Mass General Cancer Center at the San Antonio Breast Cancer Symposium 2021 Business Wire ... the need for patients to have a better understanding of their breast cancer diagnosis. Patients’ understanding of their breast cancer diagnosis is important in order to improve treatment adherence, shared decision-making, and clinical trial matching . The study shows important discrepancies between EMR and patient self-reported information, shining a light on the need for better patient education and medical records access.The study, which collected data via a ...
12/9/2021 Massive Bio — The Company that is Changing Cancer Treatment | by Massive Bio | Dec, 2021 | Medium ... trials for every cancer patient regardless of their location or financial stability, because every cancer patient deserves to know all of their available options. Using their state-of-the-art artificial intelligence (AI) powered Clinical Trial Matching System (CTMS), Massive Bio is able to pair cancer patients with the best suited clinical trial for their cancer journey. While improving cancer patient’s lives, Massive Bio also provides oncology dedicated data ...
12/2/2021 Janssen taps Tempus' AI and real-world data library for cancer drug discovery FierceBiotech ... therapies.Janssen’s data scientists will take advantage of Tempus’ platform, including its massive data library and genomic sequencing technology as well as the TIME Trial Network of healthcare providers and its accompanying clinical trial matching software.With those tools, the partners will use Tempus’ machine learning and other AI to build algorithms that can sift through clinical, genomic and trial data to identify cancer patients with specific ...
10/28/2021 Deep Lens and Southern Oncology Specialists Enter Strategic Partnership That Will Use AI-Based Solution VIPER‚Ñ¢ to Improve Clinical Trial Matching Yahoo News ... integrate molecular data feeds from Caris Life Sciences, Guardant Health, Foundation Medicine and Tempus as well as all pathology feeds to automatically identify qualified patients for clinical trials. The Deep Lens pre-screening and clinical trial matching solution is provided at no cost to oncology practices.Deep Lens is working with a significant number of community oncology practices representing every region in the U.S. It is estimated that approximately 85 ...
10/28/2021 Deep Lens and Southern Oncology Specialists Enter Strategic Partnership That Will Use AI-Based Solution VIPER‚Ñ¢ to Improve Clinical Trial Matching | Business Wire Business Wire ... integrate molecular data feeds from Caris Life Sciences, Guardant Health, Foundation Medicine and Tempus as well as all pathology feeds to automatically identify qualified patients for clinical trials. The Deep Lens pre-screening and clinical trial matching solution is provided at no cost to oncology practices.Deep Lens is working with a significant number of community oncology practices representing every region in the U.S. It is estimated that approximately 85 ...
10/28/2021 Deep Lens and Southern Oncology Specialists Enter Strategic Partnership That Will Use AI-Based Solution VIPER‚Ñ¢ to Improve Clinical Trial Matching Business Wire ... integrate molecular data feeds from Caris Life Sciences, Guardant Health, Foundation Medicine and Tempus as well as all pathology feeds to automatically identify qualified patients for clinical trials. The Deep Lens pre-screening and clinical trial matching solution is provided at no cost to oncology practices.Deep Lens is working with a significant number of community oncology practices representing every region in the U.S. It is estimated that approximately 85 ...
10/20/2021 Deep Lens and Ocala Oncology/Florida Cancer Affiliates Collaborate to Expand Clinical Research Program with AI-Based Trial Matching Solution | Financial Buzz financialbuzz.com ... they have entered into a strategic agreement to expand the well-established clinical research program and offering to patients at the Ocala-based practice. The collaboration will leverage Deep Lens’ artificial intelligence-based clinical trial matching solution, VIPER™, and other support services to identify the right patients for oncology clinical trials for which they may be eligible, right at the time of their diagnosis. Ocala Oncology/Florida Cancer ...